Claritev Corporation

NYSE:CTEV

Medical - Healthcare Information Services

Healthcare
$22.30 +1.41%

+$0.42 today

Market cap
$380.77M
Beta
0.77
P/E (TTM)
-1.8
EPS (TTM)
-$17.16
52W Low $11.50High $74.07

Volume 0.31M

Average 0.14M

CTEV Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Claritev CorporationNYSE: CTEV

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 16.69M shares rose 2.6% year over year, in line with the +2.1% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 1.6% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +2.6% holds above the trailing-twelve-month pace of +2.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
16.69M+1.6% QoQ
Last fiscal yearDec 2025
16.43M+1.8% YoY
LTMMar 2026
16.52M+2.1% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.6%——
1 year+1.8%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
16.43M USD
Year-over-year change
+1.8%
4-year CAGR
+0.2%

Weighted Avg Shares (Diluted) vs competitors

How CTEV compares with its peers on the latest reported figures

  • CTEV's LTM Mar 2026 weighted avg shares (diluted) of 16.52M shares is the 10th highest of the 11 companies compared; the peer median is 70.31M shares.
  • Its year-over-year change of +2.1% is the 6th highest of 11, against a peer median of +4.2%.
  • Over three fiscal years its annual growth of +1.0% compares with a peer median of +2.3%.
CTEV Competitors Peer median
Weighted Avg Shares (Diluted) for CTEV and competitors
Company Period LTM YoY 3-year CAGR
OPKOPKO Health, Inc.LTM Mar 2026773.08M +12.1%+1.5%
GDRXGoodRx Holdings, Inc.LTM Mar 2026346.79M -9.7%-4.7%
SANASana Biotechnology, Inc.LTM Mar 2026257.25M +9.0%+10.4%
EVHEvolent Health, Inc.LTM Mar 2026114.02M -0.8%+6.8%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202676.73M -0.1%-2.8%
INMDInMode Ltd.LTM Mar 202663.88M -16.7%-8.5%
AXGNAxoGen, Inc.LTM Sep 202653.35M +15.5%+3.0%
LFMDLifeMD, Inc.LTM Mar 202646.17M +7.9%+13.4%
DNTHDianthus Therapeutics, Inc.LTM Jun 202644.91M +27.5%+116.1%
CTEVClaritev CorporationLTM Mar 202616.52M +2.1%+1.0%
IRMDIRadimed CorporationLTM Mar 202612.86M +0.6%+0.6%
Peer median (excluding CTEV) 70.31M+4.2%+2.3%

Competitors are the stored peer set for CTEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.12B1.08B961.52M930.62M965.41M
Cost of Revenue175.29M204.1M235.47M239.4M698.84M
Gross Profit942.31M875.62M726.06M691.22M266.58M
Gross Margin84.3%81.1%75.5%74.3%27.6%
Research & Development00000
Selling, General & Admin151.1M132.14M135.99M160.22M221.52M
Operating Expenses556.19M1.24B564.07M2.08B221.52M
Depreciation & Amortization412.06M415.66M425.79M436.44M448.45M
EBITDA814.99M158.32M651.93M(1.01B)475.44M
EBITDA Margin72.9%14.7%67.8%-108.3%49.2%
Operating Income386.12M(362.73M)161.98M(1.39B)45.06M
Operating Margin34.5%-33.6%16.8%-149.4%4.7%
Interest Income30K3.5M8.23M3.13M1.56M
Interest Expense267.48M303.4M333.21M326.37M400.07M
Other Income / Expenses(250.67M)(198.01M)(269.04M)(380.78M)(418.14M)
Income Before Tax135.45M(560.74M)(107.06M)(1.77B)(373.08M)
Pre-Tax Margin12.1%-51.9%-11.1%-190.3%-38.6%
Income Tax Expense33.37M12.17M(15.36M)(124.88M)(88.8M)
Net Income102.08M(572.91M)(91.7M)(1.65B)(284.28M)
Net Margin9.1%-53.1%-9.5%-176.9%-29.4%
EPS (Basic)6.40(35.87)(5.69)(101.92)(17.30)
EPS (Diluted)6.40(35.87)(5.69)(101.92)(17.30)
Weighted Avg Shares16.28M15.97M16.13M16.15M16.43M
Weighted Avg Shares (Diluted)16.29M15.97M16.13M16.15M16.43M

Claritev Corporation

NYSE:CTEV

Intrinsic Alpha fair value

Locked

Current Price

$22.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.